Biden cancer diagnosis spurs free prostate screenings in NYC — 8 tips for first-timers
While the overall five-year survival rate for prostate cancer is an impressive 97%, that number plunges to just 37% once the disease spreads to other parts of the body, according to the American Cancer Society.
In the wake of Biden's bombshell announcement, Dr. David Shusterman, a board-certified urologist and founder of Modern Urologist, is offering support to New Yorkers.
Advertisement
4 Doctors found a 'small nodule' on Biden's prostate during a routine medical exam.
AFP via Getty Images
Shusterman is providing free prostate-specific antigen (PSA) blood tests — a key screening tool for prostate cancer — at his Midtown East office through the end of June.
Patients don't need insurance for the initial test, though follow-up care may be necessary if PSA levels come back elevated.
Advertisement
Men interested in getting screened can call (212) 991-9991 to book an appointment.
'In the time it takes to check your phone, your provider can perform a screening that could make a significant difference to your future health,' Shusterman told The Post. 'Take pride in taking that step.'
Prostate cancer 101
Biden's diagnosis was front-page news, but prostate cancer is no rarity. It's the second most common cancer among men in the US, with 1 in 8 expected to face it at some point in their lifetime, according to the National Institutes of Health.
And it's deadly serious, ranking second only to lung cancer in cancer-related deaths among American men.
Advertisement
4 Prostate cancer occurs when cells in the prostate grow uncontrollably, forming a tumor.
Peakstock – stock.adobe.com
While prostate cancer can strike at any age, the risk climbs with every birthday. Most cases are diagnosed after age 65.
Some men face even steeper odds. Black men are disproportionately affected and are more likely to be diagnosed at a younger age with more aggressive forms of the disease than other racial or ethnic groups.
Advertisement
Adding to the danger? Prostate cancer often grows slowly and has no symptoms in the early stages, meaning many men go years without knowing they have it.
When symptoms do emerge, they can mimic other common prostate problems, like an enlarged prostate or prostatitis, according to the Mayo Clinic.
Possible early warning signs include:
Blood in the urine or semen
Frequent urination
Trouble starting to pee
Waking up often at night to urinate
4 Many symptoms of prostate cancer involve changes in urination habits.
Evgeniya Primavera – stock.adobe.com
Once the cancer advances, symptoms can get more serious:
Accidental leaking of urine
Back or bone pain
Erectile dysfunction
Extreme fatigue
Unexplained weight loss
Weakness in the arms or legs
Advertisement
Doctors diagnosed Biden after he began experiencing 'increasing urinary symptoms,' according to his personal office. A physical exam revealed a 'small nodule' on his prostate, leading to further evaluation.
When to get checked
Prostate cancer can be stealthy, but early screening gives doctors the best chance of catching it when it's most treatable. Once the disease spreads to the bones, as in Biden's case, it becomes incurable.
4 PSA tests measure prostate-specific antigen in the blood, which can indicate cancer.
Alexander Raths – stock.adobe.com
Advertisement
Experts recommend men start screening conversations with their doctors at age 50. But if you're black or have a family history, start those discussions at 40 or 45.
Most health organizations don't advise screening past 70 because the potential benefits are unlikely to outweigh the harms.
A prostate cancer screening typically includes a PSA blood test — elevated levels can be a sign of prostate inflammation, enlargement or cancer — and a digital rectal exam.
'This is the part that causes the most anxiety, but it's brief and generally painless,' Shusterman said.
Advertisement
'An ultrasound tech inserts a small, lubricated probe into the rectum to visualize the prostate gland for the exact size and shape and any irregularities, such as prostate growth, into the bladder.'
Tips for first screenings
'It's completely normal to feel uneasy about your first prostate exam — but it's a sign of maturity and self-care to go through with it,' Shusterman said. Here are his tips for men undergoing their first screenings.
Don't overthink it: It's a quick exam that can yield life-saving information.
Express any concerns to your doctor: A good provider will explain each step and help reduce fear of the unknown.
Schedule wisely: Choose a time when you're not rushed or stressed, such as earlier in the day.
Wear comfortable clothing: It makes undressing and redressing easier.
Empty your bowels beforehand: This can make the prostate exam more comfortable.
Bring support : If allowed, have a friend or partner come to the appointment to ease tension.
If allowed, have a friend or partner come to the appointment to ease tension. Practice deep breathing : Even a few calming breaths in the waiting room can lower stress levels.
Even a few calming breaths in the waiting room can lower stress levels. Focus on the facts: Millions of men go through this. It's routine, and medical professionals do it all the time without judgment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
35 minutes ago
- Newsweek
Top Scientist Issues Stark mRNA Vaccine Warning to U.S.
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Rick Bright, the former director of the Biomedical Advanced Research and Development Authority (BARDA) has warned that Department of Health and Human Services' decision to cut funding for mRNA vaccine development could threaten American national security. "BARDA wasn't the only government agency making early investments in mRNA research," Bright wrote in an opinion piece for The New York Times. "The Department of Defense and the Defense Advanced Research Projects Agency had already recognized mRNA's potential for swift action against emerging biological threats, including those that might be weaponized." It comes after HHS Secretary Robert F. Kennedy Jr. announced the termination of 22 mRNA development investments and the reallocation of roughly $500 million at the beginning of this month. Why it Matters Bright said the mRNA platform had been central to the fast response to COVID-19 and that abandoning the technology would undermine the nation's ability to respond quickly to future biological threats. Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, inevitable infectious diseases crisis rears its ugly head." What To Know On August 5, the HHS confirmed it would cancel $500 million in mRNA vaccine development contracts, impacting research teams and proposals—including those from Emory University, Tiba Biotech, Pfizer, Sanofi Pasteur and others. The projects reportedly targeted respiratory viruses including seasonal influenza, COVID-19, RSV and H5N1 and included work by major industry and academic teams. Secretary Kennedy argued that the data showed mRNA vaccines had not met expectations for preventing upper respiratory infections and that HHS would shift funding toward other vaccine platforms. But Bright praised mRNA technology, saying that the "unprecedented speed" with which a COVID-19 vaccine was developed in 2020 "was possible only because years earlier, the United States had invested" in it. "This decision undercuts one of the most significant medical advances in decades, technology that could protect millions more people from the threats ahead," Bright said. "I know the stakes because I was BARDA's director when the United States made the decision to invest heavily in mRNA," he said. "That investment did not begin with Covid-19. It began in 2016, when we faced the Zika virus outbreak." "We needed a way to design a vaccine in days, not years, to protect pregnant women and their babies from devastating birth defects. Older vaccine approaches were too slow," Bright continued. "The solution was mRNA: a flexible, rapid-response technology that could be reprogrammed for any virus once its genetic sequence was known. That early investment laid the groundwork for the lightning-fast Covid-19 response four years later." Kennedy said in a post on X the time: "We reviewed the science, listened to the experts, and acted. BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu," Kennedy said in a post on X. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." Newsweek has contacted the HHS, via online inquiry form, for a response to Bright's comments. File photo of an employee of the Bavarian Red Cross (BRK) preparing the BioNTech/Pfizer vaccine against the coronavirus SARS-CoV-2 for vaccination in a vaccination center, taken in Bavaria, Germany, in January 2021. File photo of an employee of the Bavarian Red Cross (BRK) preparing the BioNTech/Pfizer vaccine against the coronavirus SARS-CoV-2 for vaccination in a vaccination center, taken in Bavaria, Germany, in January 2021. AP What People Are Saying Former BARDA director Rick Bright said in his NYT op-ed: "Like every technology, mRNA has limitations. Vaccines meant to protect against respiratory infections, whether developed through mRNA or older technologies, are generally better at averting severe disease than preventing infection. It is a scientific challenge we can address with next-generation vaccines. The answer to limitations is improvement, not abandonment. "Political narratives about mRNA have fueled confusion, which leads to mistrust, yet the scientific evidence consistently shows that this technology is safe and effective and holds enormous potential for future vaccines and treatments." Children's Health Defense, an anti-vax nonprofit founded by Kennedy Jr. which focuses on childhood health epidemics, said in a post on X: "CHD applauds this most recent announcement to defund 22 mRNA vaccine projects under BARDA. While we believe that the mRNA shots on the market are unsafe and should be off the market, this is a welcome step in the right direction. The pandemic preparedness industry as it exists today is a threat to human welfare." What Happens Next HHS said it would shift funding toward other vaccine platforms but did not provide detailed timelines or specify which programs would receive redirected support. Scientific organizations, industry groups and public-health leaders said they would assess the impact and consider next steps, while some public-health advocates announced initiatives to defend vaccine science and provide public information.
Yahoo
an hour ago
- Yahoo
Pediatrics group's COVID vaccine recommendations differ from CDC advice
The American Academy of Pediatrics is sharing new vaccine recommendations that, for the first time in 30 years, differ from U.S. government advice. In the guidance published Tuesday, the AAP is "strongly recommending" COVID-19 shots for children ages 6 months to 2 years old. For older children, shots are also advised but up to parents' discretion, the AAP said. The Centers for Disease Control and Prevention's advice is different. Under Health Secretary Robert F. Kennedy Jr.'s guidance, the CDC doesn't recommend COVID-19 shots for healthy children of any age. Instead, the administration says kids may get the shots in consultation with physicians. In a news release Tuesday, AAP President Dr. Susan J. Kressly, said the organization's immunization recommendations will continue to be "rooted in science" and in the "best interest of the health of infants, children and adolescents." "Pediatricians know how important routine childhood immunizations are in keeping children, families and their communities healthy and thriving," Kressly said. Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, told "CBS Mornings Plus" on Tuesday that there's "a lot of noise out there" when it comes to vaccines. "Parents should really stick the course and make sure that their children get all of the routine childhood vaccinations," she said, adding more announcements are expected from other professional societies in the coming weeks. Gounder added AAP's recommendations are really just reaffirming what they've previously advised. "The first encounter with COVID should be with the shot, not with the virus," she said. "There is still a very high risk in younger children, particularly 6 months to 2 years, for hospitalization and severe complications if they get COVID." The AAP's recommendations also included guidance for RSV, or respiratory syncytial virus, and flu vaccines. For RSV, the APP recommends immunizations for infants younger than 8 months old who aren't protected via a vaccine from the pregnant parent, and for children 8 to 19 months old at high risk of severe infection. For the flu, the AAP recommends annual vaccines for all children starting at 6 months old, unless they have a medical reason that would prevent them from getting the vaccine. Alaska Sen. Dan Sullivan on the Trump-Putin summit, sanctions and more MaRynn Taylor releases debut album after touring with Kelsea Ballerini What parents need to know as vaccination rates for kids continue to decline Solve the daily Crossword
Wall Street Journal
an hour ago
- Wall Street Journal
Leading Pediatrics Group Recommends Covid-19 Shots for Young Children, Differing from CDC
A prominent pediatrician group is recommending parents inoculate their young children against Covid-19, diverging from current federal health leaders who have questioned and shifted the guidance for the shots for kids. The American Academy of Pediatrics, in its immunization guidelines released Tuesday, recommended Covid-19 shots for all children ages 6 months through 23 months. Children in that age group are particularly vulnerable to severe Covid-19 infections and the vaccines would protect them from serious illness, the pediatrician group said.
